Company:  ATARA BIOTHERAPEUTICS, IN ... (ATRA)
Form Type:  10-K
Filing Date:  2/27/2020 
CIK:  0001604464 
Address:  611 GATEWAY BLVD
SUITE 900
 
City, State, Zip:  SOUTH SAN FRANCISCO, California 94080 
Telephone:  650-278-8930 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$14.81  
Change: 
-0.12 (-0.80%)  
Trade Time: 
May 22  
Market Cap: 
$873.08M
Trade ATRA now with 

© 2020  
Description of Business
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company that is developing novel treatments for patients with cancer, autoimmune and viral diseases. We have several T-cell immunotherapies in clinical development and are progressing a next-generation allogeneic chimeric antigen receptor T-cell, or CAR T program.
Register and access this filing in:     
  FORM 10-K
    PART I
      Item 1. Business
      Item 1A. Risk Factors
      Item 1B. Unresolved Staff Comments
      Item 2. Properties
      Item 3. Legal Proceedings
      Item 4. Mine Safety Disclosures
    PART II
      Item 5. Market for Registrant's Common Equity, Related ...
      Item 6. Selected Consolidated Financial Data
      Item 7. Management's Discussion and Analysis of Financial ...
        Results of Operations
        Liquidity and Capital Resources
      Item 7A. Quantitative and Qualitative Disclosures about ...
      Item 8. Financial Statements and Supplementary Data
        Report of Independent Registered Public Accounting Firm
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        Notes to Consolidated Financial Statements
      Item 9. Changes in and Disagreements with Accountants on ...
      Item 9A. Controls and Procedures
      Report of the Independent Registered Public Accounting Firm
      Report of Independent Registered Public Accounting Firm
      Item 9B. Other Information
    PART III
      Item 10. Directors, Executive Officers and Corporate Governance
      Item 11. Executive Compensation
      Item 12. Security Ownership of Certain Beneficial Owners and ...
      Item 13. Certain Relationships and Related Transactions, and ...
      Item 14. Principal Accounting Fees and Services
    PART IV
      Item 15. Exhibits, Financial Statement Schedules
    EXHIBIT INDEX
    SIGNATURES
  EXHIBIT 1.1
  EXHIBIT 4.4
  EXHIBIT 5.1
  EXHIBIT 10.22
  EXHIBIT 10.23
  EXHIBIT 10.24
  EXHIBIT 21.1
    SUBSIDIARIES
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  EXHIBIT 31.1
    CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
  EXHIBIT 31.2
    CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO